CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 63 filers reported holding CIDARA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $10,000 | +25.0% | 3,946 | 0.0% | 0.00% | – |
Q4 2020 | $8,000 | -27.3% | 3,946 | 0.0% | 0.00% | – |
Q3 2020 | $11,000 | -42.1% | 3,946 | -24.4% | 0.00% | – |
Q2 2020 | $19,000 | +58.3% | 5,223 | +252.2% | 0.00% | – |
Q1 2017 | $12,000 | -20.0% | 1,483 | 0.0% | 0.00% | – |
Q4 2016 | $15,000 | – | 1,483 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,627,670 | $1,533,591 | 1.88% |
5AM Venture Management, LLC | 1,134,511 | $1,068,936 | 0.31% |
Nantahala Capital Management | 2,538,406 | $2,391,686 | 0.20% |
BVF INC/IL | 6,861,127 | $6,464,554 | 0.17% |
Monashee Investment Management LLC | 369,099 | $347,765 | 0.14% |
West Family Investments, Inc. | 368,910 | $347,587 | 0.12% |
JEPPSON WEALTH MANAGEMENT, LLC | 137,560 | $129,609 | 0.06% |
XTX Topco Ltd | 202,758 | $191,039 | 0.03% |
GSA CAPITAL PARTNERS LLP | 136,974 | $129 | 0.01% |
Callan Capital, LLC | 103,462 | $97,482 | 0.01% |